0001214659-24-011873.txt : 20240702 0001214659-24-011873.hdr.sgml : 20240702 20240702173345 ACCESSION NUMBER: 0001214659-24-011873 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240613 FILED AS OF DATE: 20240702 DATE AS OF CHANGE: 20240702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Caroline CENTRAL INDEX KEY: 0001684087 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 241097266 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE, SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 marketforms-66487.xml PRIMARY DOCUMENT X0508 4 2024-06-13 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001684087 Young Caroline 1600 WEST END AVENUE SUITE 1300 NASHVILLE TN 37203 true false false false 1 Common Stock 2024-06-13 5 L false E 25 1.52 A 26726 D Common Stock 2024-06-14 5 L false E 48 1.50 A 26774 D Common Stock 2024-06-17 5 L false E 41 1.49 A 26815 D Common Stock 2024-06-18 5 L false E 41 1.57 A 26856 D Common Stock 2024-06-20 5 L false E 41 1.53 A 26897 D Common Stock 2024-06-21 5 L false E 41 1.49 A 26938 D Common Stock 2024-06-24 5 L false E 21 1.59 A 26959 D Common Stock 2024-06-25 5 L false E 21 1.54 A 26980 D Common Stock 2024-06-26 5 L false E 21 1.50 A 27001 D Common Stock 2024-06-27 5 L false E 21 1.52 A 27022 D Common Stock 2024-06-28 5 L false E 20 1.50 A 27042 D The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Caroline Young by /s/ John Hamm as attorney-in-fact 2024-07-02